CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$14,416,682
+64.7%
375,239
-0.8%
0.00%
+33.3%
Q1 2023$8,753,640
-12.9%
378,127
-1.5%
0.00%0.0%
Q4 2022$10,053,254
+36.5%
383,712
+2.5%
0.00%0.0%
Q3 2022$7,363,000
+164.0%
374,487
+134.9%
0.00%
+200.0%
Q2 2022$2,789,000
+52.9%
159,412
+43.0%
0.00%0.0%
Q1 2022$1,824,000
+9.5%
111,475
+9.2%
0.00%
Q4 2021$1,666,000
+54.3%
102,101
+20.7%
0.00%
Q3 2021$1,080,000
-4.4%
84,600
+5.8%
0.00%
Q2 2021$1,130,000
+76.3%
79,991
+94.1%
0.00%
Q1 2021$641,000
-2.0%
41,217
+0.0%
0.00%
Q4 2020$654,00041,1980.00%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Parallel Advisors, LLC 5$00.00%
View complete list of CHINOOK THERAPEUTICS INC shareholders